SS Innovations International, Inc. (NASDAQ: SSII) announced it has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, recognizing excellence in innovation, commercial success, industry leadership, and positive societal impact. The award highlights the growing adoption of the company's SSi Mantra surgical robotic system, which is gaining traction for its advanced technology, user-friendly design, training capabilities, and cost efficiency.
As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries, and 212 pediatric surgeries. The company also stated that approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries. This widespread adoption underscores the system's versatility and the company's commitment to making robotic surgery accessible globally.
The award comes at a time when the surgical robotics industry is rapidly evolving, with increasing demand for minimally invasive procedures. SS Innovations' focus on affordability and accessibility positions it as a key player in expanding robotic surgery to underserved regions. The SSi Mantra system's success in various specialties, including cardiac and pediatric surgery, demonstrates its potential to improve patient outcomes and reduce healthcare costs.
For more details, the full press release is available at https://ibn.fm/XWdRe. SS Innovations International, Inc. develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible. The company's product range includes the SSi Mantra surgical robotic system and the SSi Mudra surgical instruments, supporting various procedures including cardiac surgery.
This recognition not only validates SS Innovations' technological advancements but also highlights the growing importance of cost-effective robotic solutions in healthcare. As the company expands its global presence, its achievements signal a shift toward more inclusive surgical technologies that can benefit a larger segment of the population.
